the consensus for use of intravitreal aflibercept with a Treat-and Extend regimen for management of neovascular age-related macular degeneration in China

Title: the consensus for use of intravitreal aflibercept with a Treat-and Extend regimen for management of neovascular age-related macular degeneration in China
Edition: Original
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users: retinal experts
Evidence classification method:
Development unit: Shanghai General Hospital
Registration time: 2021-02-05
Registration number: IPGRP-2021CN031
Purpose of the guideline: